ASX - By Stock
|
FLT |
Re:
Next Dividend
|
|
Freeman1
|
1 |
783 |
2 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
1
|
783
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Significant funding to HIV Self-Testing in Federal Budget
|
|
Freeman1
|
39 |
12K |
1 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
39
|
12K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Freeman1
|
7 |
3.2K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
7
|
3.2K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: AT1 secures significant order for HIV self tests for LMIC
|
|
Freeman1
|
67 |
22K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
67
|
22K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Quarterly Activity Report - 31 December 2023
|
|
Freeman1
|
20 |
9.0K |
1 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
20
|
9.0K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Investor Webinar Presentation
|
|
Freeman1
|
19 |
9.0K |
3 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
19
|
9.0K
|
3
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives US FDA Clearance for FebriDx
|
|
Freeman1
|
420 |
129K |
1 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
420
|
129K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Freeman1
|
1.8K |
593K |
0 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
1.8K
|
593K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Freeman1
|
1.8K |
593K |
1 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
1.8K
|
593K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Freeman1
|
1.8K |
593K |
1 |
08/10/21 |
08/10/21 |
ASX - By Stock
|
1.8K
|
593K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Freeman1
|
1.8K |
593K |
6 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
1.8K
|
593K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Freeman1
|
1.8K |
593K |
5 |
30/09/21 |
30/09/21 |
ASX - By Stock
|
1.8K
|
593K
|
5
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
2 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
2.4K
|
777K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
1 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
2.4K
|
777K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
3 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
2.4K
|
777K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
Investor Briefing - 02/08/2021
|
|
Freeman1
|
21 |
7.6K |
1 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
21
|
7.6K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Freeman1
|
1.8K |
593K |
2 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
1.8K
|
593K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Access Bio receives FDA clearance for COVID-19 antibody test
|
|
Freeman1
|
50 |
15K |
1 |
28/06/21 |
28/06/21 |
ASX - By Stock
|
50
|
15K
|
1
|
|
ASX - By Stock
|
NAN |
Re:
WOW NAN
|
|
Freeman1
|
298 |
147K |
0 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
298
|
147K
|
0
|
|
ASX - By Stock
|
NAN |
Re:
WOW NAN
|
|
Freeman1
|
298 |
147K |
0 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
298
|
147K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
Media Update
|
|
Freeman1
|
1.8K |
593K |
3 |
24/04/21 |
24/04/21 |
ASX - By Stock
|
1.8K
|
593K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
1 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
2.4K
|
777K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
0 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
2.4K
|
777K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
0 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
2.4K
|
777K
|
0
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
6 |
28/01/21 |
28/01/21 |
ASX - By Stock
|
2.4K
|
777K
|
6
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
3 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
2.4K
|
777K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
2 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
2.4K
|
777K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
1 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
2.4K
|
777K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
3 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
2.4K
|
777K
|
3
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
1 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
2.4K
|
777K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
2 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
2.4K
|
777K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
1 |
07/11/20 |
07/11/20 |
ASX - By Stock
|
2.4K
|
777K
|
1
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
2 |
07/11/20 |
07/11/20 |
ASX - By Stock
|
2.4K
|
777K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
2 |
07/11/20 |
07/11/20 |
ASX - By Stock
|
2.4K
|
777K
|
2
|
|
ASX - By Stock
|
AT1 |
Re:
AT1 FY21 - General Discussion + FA
|
|
Freeman1
|
2.4K |
777K |
1 |
06/11/20 |
06/11/20 |
ASX - By Stock
|
2.4K
|
777K
|
1
|
|